Literature DB >> 6635788

The Boston brace in thoracic scoliosis. A preliminary report.

E L Laurnen, J W Tupper, M P Mullen.   

Abstract

The Boston Brace has been reserved mainly for treating scoliosis curves with an apex below T9 while the Milwaukee superstructure has been recommended as the choice of treatment for higher thoracic curves. This paper is an analysis of the preliminary result of treatment of 300 thoracic curves with an apex of T9 or higher treated with the Boston underarm brace from 1975 through 1979. Preliminary success of Boston Bracing for thoracic curves is dependent upon placement of the thoracic pad adjacent to the ribs at the apex of the convexity and a high axillary crutch on the concave side of the curve. Boston Bracing of thoracic curves appeared initially favorable at apices T9, T8, T7, and possibly T6. Higher thoracic curves are difficult to control, and should be treated with the standard Milwaukee type brace with uprights.

Entities:  

Mesh:

Year:  1983        PMID: 6635788     DOI: 10.1097/00007632-198305000-00009

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  4 in total

1.  Design of the Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST).

Authors:  Stuart L Weinstein; Lori A Dolan; James G Wright; Matthew B Dobbs
Journal:  Spine (Phila Pa 1976)       Date:  2013-10-01       Impact factor: 3.468

2.  Evaluation of the efficiency of Boston brace on scoliotic curve control: A review of literature.

Authors:  Mohammad Taghi Karimi; Timon Rabczuk
Journal:  J Spinal Cord Med       Date:  2019-02-27       Impact factor: 1.985

3.  Brace technology thematic series: the 3D Rigo Chêneau-type brace.

Authors:  Manuel Rigo; Mina Jelačić
Journal:  Scoliosis Spinal Disord       Date:  2017-03-16

Review 4.  Spontaneous fracture of the sternum in a child being treated in a Boston brace for kyphoscoliosis. A case report and review of the literature.

Authors:  P Korovessis; G Sdougos; T Dimas
Journal:  Eur Spine J       Date:  1994       Impact factor: 3.134

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.